Philippe Othenin-Girard

TL;DR: Central and/or peripheral contact between the ICL and the crystalline lens may be responsible for the high incidence of ASCC formation in eyes with an implantable contact lens used for moderate to high myopia.

TL;DR: This study confirms the mutation hot spot at positions R124 and R555 with nearly 50% of the mutations targeting these two amino acids (24/50) and confirms the genotype-phenotype correlation is domain specific, with all changes occurring at the boundary or within the fasc4 domain.

TL;DR: Implantation of an ICL was effective in correcting moderate to high myopia and the predictability of the refractive outcome must be improved, as the new generation of ICLs for myopia offers a better vault over the crystalline lens than the older models (ICM V3), which should decrease the risk of cataract.

TL;DR: Diclofenac sodium seems to be as potent as dexamethasone phosphate, as good an anti‐inflammatory agent, and may replace corticosteroid therapy after cataract surgery.

TL;DR: This retrospective single center study indicates that ICL implantation provides good long-term safety and stability of refraction in patients with high myopia compared with similar short-term studies, but the rates of cataract formation and ocular hypertension at 10 years have important clinical implications.